These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 37045827)

  • 1. Patient-derived xenograft models in cancer therapy: technologies and applications.
    Liu Y; Wu W; Cai C; Zhang H; Shen H; Han Y
    Signal Transduct Target Ther; 2023 Apr; 8(1):160. PubMed ID: 37045827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies.
    Liu L; Wu M; Huang A; Gao C; Yang Y; Liu H; Jiang H; Yu L; Huang Y; Wang H
    J Transl Med; 2023 Sep; 21(1):611. PubMed ID: 37689699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models.
    Okada S; Vaeteewoottacharn K; Kariya R
    Cells; 2019 Aug; 8(8):. PubMed ID: 31412684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models.
    Hynds RE; Huebner A; Pearce DR; Hill MS; Akarca AU; Moore DA; Ward S; Gowers KHC; Karasaki T; Al Bakir M; Wilson GA; Pich O; Martínez-Ruiz C; Hossain ASMM; Pearce SP; Sivakumar M; Ben Aissa A; Grönroos E; Chandrasekharan D; Kolluri KK; Towns R; Wang K; Cook DE; Bosshard-Carter L; Naceur-Lombardelli C; Rowan AJ; Veeriah S; Litchfield K; Crosbie PAJ; Dive C; Quezada SA; Janes SM; Jamal-Hanjani M; Marafioti T; ; McGranahan N; Swanton C
    Nat Commun; 2024 May; 15(1):4653. PubMed ID: 38821942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study.
    Xu C; Yan L; An Q; Zhang S; Guan X; Wang Z; Lv A; Liu D; Liu F; Dong B; Zhao M; Tian X; Hao C
    Int J Med Sci; 2022; 19(8):1241-1253. PubMed ID: 35928724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-derived xenograft (PDX) models, applications and challenges in cancer research.
    Abdolahi S; Ghazvinian Z; Muhammadnejad S; Saleh M; Asadzadeh Aghdaei H; Baghaei K
    J Transl Med; 2022 May; 20(1):206. PubMed ID: 35538576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and genetically characterization of patient-derived xenograft models of cervical cancer.
    Zou S; Ye M; Zhang JA; Ji H; Chen Y; Zhu X
    BMC Med Genomics; 2022 Sep; 15(1):191. PubMed ID: 36076209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fidelity of cancer cells in PDX models: Characteristics, mechanism and clinical significance.
    Shi J; Li Y; Jia R; Fan X
    Int J Cancer; 2020 Apr; 146(8):2078-2088. PubMed ID: 31479514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer.
    Bonazzi VF; Kondrashova O; Smith D; Nones K; Sengal AT; Ju R; Packer LM; Koufariotis LT; Kazakoff SH; Davidson AL; Ramarao-Milne P; Lakis V; Newell F; Rogers R; Davies C; Nicklin J; Garrett A; Chetty N; Perrin L; Pearson JV; Patch AM; Waddell N; Pollock PM
    Genome Med; 2022 Jan; 14(1):3. PubMed ID: 35012638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humanized mouse models for anti-cancer therapy.
    Baietti MF; Leucci E
    Methods Cell Biol; 2024; 183():317-333. PubMed ID: 38548416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Knowledge and practice of patient-derived xenograft models in leukemia].
    Kato I
    Rinsho Ketsueki; 2022; 63(9):1335-1343. PubMed ID: 36198560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application and development of patient-derived tumor xenograft model in translational medicine of tumor].
    Wang Z; Zhu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):596-600. PubMed ID: 28534338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization.
    Sun S; Zhang Z
    Front Med; 2016 Mar; 10(1):104-10. PubMed ID: 26926009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug Development Based on Intracellular Pharmacokinetic Analysis of Molecular Target Drug in Mice Bearing Patient-derived Xenograft Model].
    Hamada A
    Yakugaku Zasshi; 2020; 140(5):641-648. PubMed ID: 32378664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.
    Prasetyanti PR; van Hooff SR; van Herwaarden T; de Vries N; Kalloe K; Rodermond H; van Leersum R; de Jong JH; Franitza M; Nürnberg P; Todaro M; Stassi G; Medema JP
    Int J Cancer; 2019 Jan; 144(2):366-371. PubMed ID: 30151914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and Preclinical Therapy of Patient-derived Hepatocellular Carcinoma Xenograft Model.
    Wu Y; Wang J; Zheng X; Chen Y; Huang M; Huang Q; Xiao W; Wei H; Tian Z; Sun R; Sun C
    Immunol Lett; 2020 Jul; 223():33-43. PubMed ID: 32335145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine.
    Rivera M; Fichtner I; Wulf-Goldenberg A; Sers C; Merk J; Patone G; Alp KM; Kanashova T; Mertins P; Hoffmann J; Stein U; Walther W
    Neoplasia; 2021 Jan; 23(1):21-35. PubMed ID: 33212364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
    Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
    Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-derived xenograft (PDX) models in basic and translational breast cancer research.
    Dobrolecki LE; Airhart SD; Alferez DG; Aparicio S; Behbod F; Bentires-Alj M; Brisken C; Bult CJ; Cai S; Clarke RB; Dowst H; Ellis MJ; Gonzalez-Suarez E; Iggo RD; Kabos P; Li S; Lindeman GJ; Marangoni E; McCoy A; Meric-Bernstam F; Piwnica-Worms H; Poupon MF; Reis-Filho J; Sartorius CA; Scabia V; Sflomos G; Tu Y; Vaillant F; Visvader JE; Welm A; Wicha MS; Lewis MT
    Cancer Metastasis Rev; 2016 Dec; 35(4):547-573. PubMed ID: 28025748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in building clinically relevant patient-derived tumor xenograft models for cancer research.
    Wang W; Li Y; Lin K; Wang X; Tu Y; Zhuo Z
    Animal Model Exp Med; 2023 Oct; 6(5):381-398. PubMed ID: 37679891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.